Thrombospondin-1 and transforming growth factor-beta1 promote breast tumor cell invasion through upregulation of the plasminogen/plasmin system

被引:65
作者
Albo, D
Berger, DH
Wang, TN
Hu, XL
Rothman, V
Tuszynski, GP
机构
[1] ALLEGHENY UNIV HLTH SCI,DEPT SURG,PHILADELPHIA,PA 19102
[2] ALLEGHENY UNIV HLTH SCI,DEPT PATHOL,PHILADELPHIA,PA 19102
[3] ALLEGHENY UNIV HLTH SCI,DEPT LAB MED,PHILADELPHIA,PA 19102
关键词
D O I
10.1016/S0039-6060(97)90043-X
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Pericellular proteolysis is crucial in tumor cell invasion. The plasminogen/plasmin system is one of the main protease systems involved in cancer progression. Thrombospondin-1 (TSP-1) through activation of transforming growth factor-beta 1 (TGF-beta 1) up-regulates the main plasminogen activator the urokinase-type plasminogen activator (uPA). The objectives of this study were to determine the role of TSP-1 and TGF-beta 1 in the localization of the plasminogen/plasmin system to the tumor cell surface by the uPA receptor (uPAR) and to determine its effect in breast tumor cell invasion. Methods. The effect of TSP-1 and TGF-beta 1 in uPAR expression was determined in MDA-MB-231 human breast cancer cells by enzyme-linked immunosorbent assay and Western blot analysis. Their effect and the role of the plasminogen/plasmin system in breast tumor cell invasion were studied with a Boyden Chamber assay. Results. uPAR expression was up-regulated more than twofold by both TSP-1 and TGF-P1. The effect of TSP-1 involved its receptor and the activation of TGF-beta 1 by TSP-1. Breast tumor cell invasion was up-regulated sevenfold to eightfold by both TSP-1 and TGF-beta 2 compared with the control group. Antibodies against uPA or uPAR neutralized the TSP-1- and TGF beta 1-promoted breast tumor cell invasion. Conclusions. TSP-1, through the activation of endogenous TGF-beta 1, up-regulates the plasminogen/plasmin system and promotes tumor cell invasion in breast cancer cells.
引用
收藏
页码:493 / 499
页数:7
相关论文
共 27 条
[1]  
ALBINI A, 1987, CANCER RES, V47, P3239
[2]   THROMBOSPONDIN (TSP) AND TRANSFORMING GROWTH-FACTOR-BETA-1 (TGF-BETA) PROMOTE HUMAN A549 LUNG-CARCINOMA CELL PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAL-1) PRODUCTION AND STIMULATE TUMOR-CELL ATTACHMENT IN-VITRO [J].
ALBO, D ;
ARNOLETTI, JP ;
CASTIGLIONI, A ;
GRANICK, MS ;
SOLOMON, MP ;
ROTHMAN, VL ;
TUSZYNSKI, GP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 203 (02) :857-865
[3]   COMPUTER-ASSISTED IMAGE-ANALYSIS OF TUMOR SECTIONS FOR A NEW THROMBOSPONDIN RECEPTOR [J].
ARNOLETTI, JP ;
ALBO, D ;
JHALA, N ;
GRANICK, MS ;
SOLOMON, MP ;
ATKINSON, B ;
ROTHMAN, VL ;
TUSZYNSKI, GP .
AMERICAN JOURNAL OF SURGERY, 1994, 168 (05) :433-436
[4]  
ARNOLETTI JP, 1995, CANCER, V76, P998, DOI 10.1002/1097-0142(19950915)76:6<998::AID-CNCR2820760613>3.0.CO
[5]  
2-0
[6]   THE UROKINASE RECEPTOR AND REGULATION OF CELL-SURFACE PLASMINOGEN ACTIVATION [J].
BLASI, F ;
BEHRENDT, N ;
CUBELLIS, MV ;
ELLIS, V ;
LUND, LR ;
MASUCCI, MT ;
MOLLER, LB ;
OLSON, DP ;
PEDERSEN, N ;
PLOUG, M ;
RONNE, E ;
DANO, K .
CELL DIFFERENTIATION AND DEVELOPMENT, 1990, 32 (03) :247-254
[7]   UROKINASE AND UROKINASE RECEPTOR - A PARACRINE AUTOCRINE SYSTEM REGULATING CELL-MIGRATION AND INVASIVENESS [J].
BLASI, F .
BIOESSAYS, 1993, 15 (02) :105-111
[8]  
Costantini V, 1996, CANCER-AM CANCER SOC, V77, P1079, DOI 10.1002/(SICI)1097-0142(19960315)77:6<1079::AID-CNCR12>3.0.CO
[9]  
2-Z
[10]   PLASMINOGEN ACTIVATION BY RECEPTOR-BOUND UROKINASE [J].
ELLIS, V ;
DANO, K .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1991, 17 (03) :194-200